<--- Back to Details
First PageDocument Content
Bacteria / Pneumococcal polysaccharide vaccine / Pneumococcal vaccine / Pneumococcal conjugate vaccine / Asplenia / Conjugate vaccine / Influenza vaccine / Streptococcus pneumoniae / FluMist / Vaccines / Medicine / Biology
Date: 2013-09-13 14:20:24
Bacteria
Pneumococcal polysaccharide vaccine
Pneumococcal vaccine
Pneumococcal conjugate vaccine
Asplenia
Conjugate vaccine
Influenza vaccine
Streptococcus pneumoniae
FluMist
Vaccines
Medicine
Biology

Who Should Receive the Vaccine? Pneumococcal Conjugate Vaccine

Add to Reading List

Source URL: www.immunize.ca

Download Document from Source Website

File Size: 502,74 KB

Share Document on Facebook

Similar Documents

Trabajos Libres 2017 MENINGITIS POR STREPTOCOCCUS PNEUMONIAE EN LA ERA DE LA VACUNACION Título: ANTINEUMOCICCICA: REPORTE DE CASO Autor: PANDURO VALDEZ LI Co-autor: BECERRA TREJO BG; ESPINOZA OLIVA MM

DocID: 1vmc2 - View Document

Ministerio de Salud BOLETÍN VIGILANCIA DE LABORATORIO Vigilancia de Laboratorio de Streptococcus pneumoniae

DocID: 1uREL - View Document

1 Vol. 4, No. 11, NoviembreVigilancia de Enfermedad Invasora Streptococcus pneumoniae. Chile, 2007 – 2014.

DocID: 1uDbc - View Document

Ministerio de Salud VIGILANCIA DE LABORATORIO Comportamiento de Streptococcus pneumoniae serotipos 3 y 19 A en

DocID: 1udYJ - View Document

Pneumonia / Bacteria / Microbiology / Medicine / Pneumococcal pneumonia / Antimicrobial resistance / Streptococcus pneumoniae / Pneumococcal infection / Bacterial pneumonia

LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held

DocID: 1rhtI - View Document